Physician profile
Jonathan G Yerasimides
NPI 1295763225
$4,272,197.05
in general payments reported to CMS, 2019-2025
12 companies · $370K in 2025
The $370K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241K · 2020: $241K · 2021: $418K · 2022: $475K · 2023: $603K · 2024: $1.9M · 2025: $370K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.1M · Education: $456K · Consulting Fee: $275K · Travel and Lodging: $43K · Long Term Medical Supply Or Device Loan: $22K · Food and Beverage: $6,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,095,802.84 |
| Education | $455,912.50 |
| Consulting Fee | $274,799.40 |
| Travel and Lodging | $43,130.08 |
| Long Term Medical Supply Or Device Loan | $22,131.14 |
| Food and Beverage | $6,410.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,270,544.17 | 2019-2025 | Avenir, G7, Arcos |
| Stryker Corporation | $831.73 | 2019-2024 | Prophecy, Inbone, Invision |
| Osteoremedies, LLC | $155.53 | 2019 | |
| Integrity Orthopaedics, INC. | $149.44 | 2024 | Integrity Orthopaedics |
| Depuy Synthes Sales INC. | $110.50 | 2021 | |
| Heron Therapeutics, INC. | $100.80 | 2025 | Zynrelef |
| Kci USA, INC. | $94.50 | 2021 | |
| Medical Device Business Services, INC. | $86.18 | 2019 | |
| Medtronic, INC. | $76.66 | 2021-2025 | Plasmablade(Tm) |
| Smith+Nephew, INC. | $20.90 | 2024 | Renasys Touch, Pico 14, Pico 7 |
| Avanos Medical | $15.46 | 2019 | |
| Exactech, INC. | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Yerasimides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.